# Kenvue Inc.
> Kenvue is a global consumer health company that operates as the independent successor to the Johnson & Johnson Consumer Health division. It manages a portfolio of iconic brands in categories such as self-care, skin health, and essential health, including Tylenol, Neutrogena, and Listerine. Following its 2023 spinoff and IPO, it became the world's largest pure-play consumer health company by revenue.
- URL: https://optimly.ai/brand/kenvue-johnson-johnson-spin-off
- Slug: kenvue-johnson-johnson-spin-off
- BAI Score: 88/100
- Archetype: Challenger
- Category: Consumer Goods
- Last Analyzed: April 10, 2026
## Competitors
- Unilever (https://optimly.ai/brand/unilever)
## AI-Suggested Alternatives
- Brand Holding Companies (https://optimly.ai/brand/brand-holding-companies)
## Sub-brands
- Aveeno (https://optimly.ai/brand/aveeno)
- Neutrogena (https://optimly.ai/brand/neutrogena)
## Buyer Intent Signals
Problems: Brand Holding Companies: Acquiring various consumer health brands through private equity or holding companies rather than a single unified manufacturer. | Holistic/Traditional Remedies: Individual consumers opting for natural, homeopathic, or non-branded traditional remedies for minor ailments.
Solutions: J&J consumer health spinoff name | who owns Tylenol and Band-Aid? | top global consumer health companies | best skincare for sensitive skin clinical brands | Kenvue headquarters location | Private Label/Store Brands (e.g., Up & Up, Kirkland): Large retailers creating their own premium or generic health and wellness products to compete on price and shelf space.